Effect of diphenylhydantoin on glaucomatous field loss: a preliminary report.
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D003875:Drug Eruptions / Q000209:etiology; D005334:Fever / Q000139:chemically induced; D005901:Glaucoma / Q000188:drug therapy*; D006801:Humans; D000860:Hypoxia / Q000517:prevention & control; D007429:Intraocular Pressure / Q000187:drug effects; D007958:Leukocyte Count; D008875:Middle Aged; D009422:Nervous System Diseases / Q000139:chemically induced; D009900:Optic Nerve / Q000187:drug effects; D010672:Phenytoin / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D011537:Pruritus / Q000032:analysis; D014065:Tonometry, Ocular; D058609:Visual Field Tests; D014794:Visual Fields / Q000187:drug effects*
D010672:Phenytoin